- In April 2024, Viz.ai, a U.S.-based leader in AI-powered stroke care, announced the expansion of its Intelligent Care Coordination Platform to more than 1,500 hospitals across the country. This platform uses artificial intelligence to detect large vessel occlusions (LVO) from CT scans and automatically alert stroke teams, significantly reducing response time and improving patient outcomes. This development showcases Viz.ai’s pivotal role in enhancing stroke care efficiency through AI-driven automation and real-time communication tools
- In March 2024, the Mayo Clinic launched a collaborative telestroke program with several rural hospitals across the Midwest, enabling 24/7 access to neurologists for stroke evaluation and treatment. This initiative leverages high-definition video conferencing and integrated diagnostic tools to bridge care gaps in underserved areas. The program highlights Mayo Clinic’s commitment to reducing geographic disparities in acute stroke care by advancing real-time, remote intervention capabilities
- In March 2024, the American Heart Association (AHA) published new clinical practice guidelines emphasizing the role of telestroke in improving door-to-needle times and increasing access to thrombolytic therapy. These guidelines promote the standardization of telestroke protocols across emergency departments, further validating telestroke as a critical component of modern stroke management. The publication reinforces the growing recognition of telestroke services in national stroke care strategies
- In February 2024, Ochsner Health, based in Louisiana, expanded its Telestroke Network to include over 60 partner hospitals. This network facilitates rapid stroke diagnosis and decision-making through remote consultations, supporting hospitals without on-site neurologists. Ochsner’s initiative demonstrates how regional health systems are scaling telestroke infrastructure to provide equitable access to expert neurological care across their service areas
- In January 2024, Genentech, a biotechnology leader, partnered with a health tech startup to pilot an AI-enhanced telestroke platform aimed at streamlining treatment pathways for acute ischemic stroke. The collaboration integrates clinical decision support tools with remote imaging analysis to improve care delivery efficiency. This project underscores the pharmaceutical industry’s growing role in digital health innovation and its commitment to advancing acute stroke care through technology-enabled solutions
